PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.47%
Revenue growth above 1.5x ADI's 0.41%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
1.64%
Gross profit growth above 1.5x ADI's 0.95%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
3.82%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
1.96%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
0.82%
Net income growth under 50% of ADI's 1.68%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.53%
EPS growth under 50% of ADI's 2.11%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.08%
Diluted EPS growth at 50-75% of ADI's 2.13%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.11%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Dividend reduction while ADI stands at 13.45%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
20.60%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-126.40%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
80.64%
10Y revenue/share CAGR under 50% of ADI's 201.49%. Michael Burry would suspect a lasting competitive disadvantage.
21.37%
5Y revenue/share CAGR under 50% of ADI's 58.26%. Michael Burry would suspect a significant competitive gap or product weakness.
41.12%
3Y revenue/share CAGR at 50-75% of ADI's 80.74%. Martin Whitman would question if the firm lags behind competitor innovations.
152.14%
10Y OCF/share CAGR in line with ADI's 161.25%. Walter Schloss would see both as similarly efficient over the decade.
-17.56%
Negative 5Y OCF/share CAGR while ADI is at 10.47%. Joel Greenblatt would question the firm’s operational model or cost structure.
-17.95%
Negative 3Y OCF/share CAGR while ADI stands at 83.92%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
216.94%
Net income/share CAGR at 75-90% of ADI's 262.09%. Bill Ackman would press for strategic moves to boost long-term earnings.
31.88%
Below 50% of ADI's 88.89%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
25.88%
Below 50% of ADI's 166.44%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
74.95%
Below 50% of ADI's 391.80%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
61.29%
Below 50% of ADI's 149.67%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
110.37%
3Y equity/share CAGR at 75-90% of ADI's 126.68%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
342.27%
10Y dividend/share CAGR above 1.5x ADI's 153.90%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
99.75%
5Y dividend/share CAGR 1.25-1.5x ADI's 79.14%. Bruce Berkowitz verifies that high dividend hikes remain sustainable, not a sign of over-distribution.
37.90%
3Y dividend/share CAGR similar to ADI's 38.89%. Walter Schloss finds parallel short-term dividend strategies for both companies.
4.21%
Our AR growth while ADI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.41%
Inventory growth well above ADI's 8.22%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.88%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.46%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
10.79%
Debt growth far above ADI's 2.84%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.84%
R&D growth drastically higher vs. ADI's 0.40%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.